This inspired the researchers to use data from Swedish nationwide registries to investigate how the use of individual GLP-1 agonists including exenatide, liraglutide, dulaglutide (Trulicity, Eli Lilly & Co.) and semaglutide (Ozempic/Wegovy, Novo Nordisk) would influence the risk for hospitalization due to AUD compared with periods of nonuse, with hospitalization due to substance use disorder (SUD), somatic reasons or suicide attempt serving as secondary outcomes
Substance use in adolescence and psychosis: clarifying the relationship
However, the cost of tirzepatide raises contentious issues regarding its cost-effectiveness
Curiously, the Na + cavity remains occluded, without an obvious exit pathway or solvent accessibility
If these medications work for alcohol addiction, we do not expect that they will work for everybody, Leggio said in a conversation with Medscape